Csenge Advisory Group’s Idexx Laboratories IDXX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $395K | Sell |
770
-4
| -0.5% | -$2.05K | 0.02% | 478 |
|
2025
Q1 | $318K | Sell |
774
-171
| -18% | -$70.3K | 0.02% | 514 |
|
2024
Q4 | $391K | Sell |
945
-71
| -7% | -$29.4K | 0.02% | 493 |
|
2024
Q3 | $484K | Sell |
1,016
-4
| -0.4% | -$1.91K | 0.03% | 431 |
|
2024
Q2 | $497K | Buy |
1,020
+77
| +8% | +$37.5K | 0.03% | 403 |
|
2024
Q1 | $509K | Buy |
943
+166
| +21% | +$89.6K | 0.03% | 429 |
|
2023
Q4 | $431K | Buy |
777
+225
| +41% | +$125K | 0.03% | 438 |
|
2023
Q3 | $241K | Buy |
552
+40
| +8% | +$17.5K | 0.02% | 539 |
|
2023
Q2 | $257K | Buy |
+512
| New | +$257K | 0.02% | 537 |
|
2022
Q1 | – | Sell |
-978
| Closed | -$625K | – | 654 |
|
2021
Q4 | $625K | Sell |
978
-59
| -6% | -$37.7K | 0.06% | 290 |
|
2021
Q3 | $647K | Buy |
1,037
+59
| +6% | +$36.8K | 0.05% | 310 |
|
2021
Q2 | $625K | Sell |
978
-38
| -4% | -$24.3K | 0.06% | 291 |
|
2021
Q1 | $511K | Buy |
1,016
+328
| +48% | +$165K | 0.05% | 269 |
|
2020
Q4 | $344K | Buy |
+688
| New | +$344K | 0.04% | 295 |
|
2018
Q4 | – | Sell |
-2
| Closed | – | – | 772 |
|
2018
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1290 |
|